全球糖尿病護理設備和藥物市場規模、佔有率、成長分析、副產品（血糖監測設備和胰島素輸送設備）、最終用途（醫院、門診手術中心）- 2024-2031 年產業預測

Global Diabetes Care Devices and Drugs Market Size, Share, Growth Analysis, By Product(Blood glucose monitoring devices and Insulin delivery devices), By End use(Hospitals, Ambulatory surgery centres) - Industry Forecast 2024-2031

出版日期: 2024年04月22日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球糖尿病護理設備和藥物市場規模為335.3億美元，預計將從2023年的361.8億美元成長到2031年的664.7億美元，在預測期內（2024-2031年）複合年成長率為7.9% 。

胰臟產生的荷爾蒙胰島素調節血糖水平。當身體無法產生足夠的胰島素來調節血糖水平時，就會出現糖尿病。透過糖尿病護理設備監測血糖值。連續血糖監測儀是糖尿病患者用來全天追蹤和關注血糖水平的設備。患有糖尿病的人可能會發現這種穿戴式裝置很有幫助，因為它可以促進更輕鬆的血糖管理。二十一世紀全球健康面臨的最大問題之一是糖尿病。每年越來越多的人受到這種疾病的影響，這可能會造成嚴重的後果。國際糖尿病聯盟 (IDF) 估計，美國有 5.37 億 20 歲至 79 歲的成年人患有糖尿病。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2023 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率 (%), 2023

主要公司簡介

Novo Nordisk A/S
Eli Lilly and Company
Sanofi SA
Merck & Co., Inc.
Abbott Laboratories
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
Johnson & Johnson Services, Inc.
Medtronic plc
Dexcom, Inc.
Insulet Corporation
Ypsomed AG
Ascensia Diabetes Care Holdings AG
Tandem Diabetes Care, Inc.
Senseonics Holdings, Inc.
B. Braun Melsungen AG
Terumo Corporation
AstraZeneca
Boehringer Ingelheim International GmbH
Novartis AG

簡介目錄

Product Code: SQMIG35G2119

Global Diabetes Care Devices and Drugs Market size was valued at USD 33.53 billion in 2022 and is poised to grow from USD 36.18 billion in 2023 to USD 66.47 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The hormone insulin produced by the pancreas regulates blood glucose levels. When the body does not create enough insulin to regulate blood glucose levels, diabetes develops. Blood glucose levels are monitored by means of diabetes care devices. A continuous glucose monitor is a piece of equipment used by diabetic patients to track and keep an eye on their blood sugar levels all day long. Those who have diabetes may find this wearable device helpful as it can facilitate easier glucose management. One of the biggest issues facing global health in the twenty-first century is diabetes. An increasing number of people are affected by the illness each year, which can have serious consequences. The International Diabetes Federation (IDF) estimates that 537 million adults in the United States between the ages of 20 and 79 have diabetes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Care Devices and Drugs Marketand to estimate the size of various other dependent submarkets. The research methodology used to estimate the Market size includes the following details: The key players in the Market were identified through secondary research, and their Market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top Market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Care Devices and Drugs Market Segmental Analysis

Global diabetes care devices and drugs market is segmented based on product, end use and region. Based on product, global diabetes care devices and drugs market is sub-segmented into blood glucose monitoring devices and insulin delivery devices. Based on end use, diabetes care devices and drugs market is sub-segmented into hospitals, ambulatory surgery centres, diagnostic centres, and home care. Based on region, global diabetes care devices and drugs market is sub-segmented into North America, Europe, Asia Pacific, Latin America, and MEA.

Drivers of the Global Diabetes Care Devices and Drugs Market

One of the main factors propelling the growth of the global market for diabetes care devices and pharmaceuticals is the launch of new products in the form of treatment devices and monitoring systems. For instance, Universidade de Lisboa researchers in Portugal revealed in April 2020 that chitosan coating of insulin-loaded nanoparticles could improve insulin oral delivery. Growing R&D expenditures and research partnerships can open up more avenues for the market's continued expansion.

Restraints in the Global Diabetes Care Devices and Drugs Market

The global market for diabetes care devices and medications may not grow as quickly as it could due to harsh limitations, rising obesity rates, and a lack of reimbursement in some countries. The global market for diabetic devices and medications is predicted to grow slowly because to a lack of knowledge about diabetes diagnosis and treatment, particularly in developing nations.

Market Trends of the Global Diabetes Care Devices and Drugs Market

The global market trend is expected to be good due to the coronavirus pandemic. Due to the increased risk of infection from the coronavirus for those with diabetes, there has been a rise in demand in recent years for diabetes monitoring tools. Devices were essential for illness management since people with diabetes wanted to minimize hospital stays and visits.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Diabetes Care Devices and Drugs Market by Product

Market Overview
Blood glucose monitoring devices and Insulin delivery devices

Global Diabetes Care Devices and Drugs Market by End use

Market Overview
Hospitals
Ambulatory surgery centres
Diagnostic centres
Home care

Global Diabetes Care Devices and Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dexcom, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Insulet Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ascensia Diabetes Care Holdings AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tandem Diabetes Care, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Senseonics Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments